Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: Resveratrol and First-degree Relatives of Type 2 Diabetic Patients [NA]

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating resveratrol in first-degree relatives of individuals with type 2 diabetes (prediabetes).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Pre-diabetes | NA | Status: COMPLETED